CareRx Corp (CRRX)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 3.300 |
|---|---|
| 52-week range | 3.060 – 3.928 |
| Return, 1 month / 3 months | +3.1% / −1.7% |
| Return, 1 year / 3 years | −5.1% / +87.7% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 28.0% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 0.09M CAD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CareRx Corp is a Canadian pharmacy services company that focuses on residents of long-term care homes, retirement communities and other group living settings. It supplies prescription medications and related pharmacy services to these facilities and their residents, working closely with care teams to manage medication needs. The company is based in Canada and serves institutional clients rather than the general retail pharmacy market, combining dispensing with clinical support for seniors and other residents in care settings.
CareRx Corp trades under the code CRRX on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CareRx Corp (CRRX) trades on the Toronto Exchange in Canada. It last closed at CAD 3.300 on 19 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 561 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.1% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.2% | ||
| From 52-week high | -14.9% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -11.8% | ||
| 12-month return, skipping the last month | -8.0% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +3.1% |
| 3 months | −1.7% |
| 6 months | −11.8% |
| 1 year | −5.1% |
| 3 years | +87.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 3.221 / 3.479 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.081 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | CAD 0.0220 |
| 23 Jun 2026 | CAD 0.0200 |
| 19 Mar 2026 | CAD 0.0200 |
| 23 Dec 2025 | CAD 0.0200 |
| 23 Sep 2025 | CAD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.